U.S. FDA Leadership from Three Centers and OII Headline the Center Office Updates Session of the 2026 PDA/FDA Joint Regulatory Conference
Original HTML

SORRY, WE COULDN’T FIND THAT PAGE

The page you are searching for does not exist.

Either it has moved, or the link is broken.

ERROR CODE: 404

Please use the search feature, return to the home page, or visit one of the following:

 

News

Products

Resources

Contact PR Newswire

 

Send a Release

Online Member Center

ProfNet℠

Become a Member

Journalists

 

Asia

Brazil

Canada

Czech

Denmark

Finland

France

Germany

India

Israel

Italy

Mexico

 

Middle East

Netherlands

Norway

Poland

Portugal

Russia

Slovakia

Spain

Sweden

United Kingdom

United States

Class (B2B/B2C)
Ignore
Ingest Status
Error
Dedupe hash
a8feb3674389083d6bbf4cac68a14b66
Press Eligible
No
Press Eligible Reason
Content is a 404 error page with no actual article text. The page does not exist or is broken, providing no business information to evaluate.
Source Name
Unknown Company
Original Summary

<p>PDA announced today that senior leaders from the FDA's centers for drugs, biologics and veterinary medicine as well as the Office of Inspections and Investigations will participate in the plenary on Monday, Sept. 14, as part of the 2026 PDA/FDA Joint Regulatory Conference in Washington, D....</p>

Original Link
Original Source